have shown that BM-MSCs from p53-deficient mice (p53 mBM-MSCs) can regulate the Wnt/β-catenin pathway and deliver UBr2 to target cells, thereby promoting the growth and metastasis of gastric cancer (GC) (52). The gene discussed is UBR2; the disease is gastric cancer.